nach oben

Erschienen in:

2020 | OriginalPaper | Buchkapitel

The Importance of Emerging Industries: The Case of Biopharma

verfasst von : Cristina Porumboiu

Erschienen in: Eurasian Economic Perspectives

Verlag: Springer International Publishing

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

The aim of this chapter is to highlight the importance of emerging industries in a continuously changing and globalized world, dominated by constant shifts of consumers’ behavior, when the arising new needs fuel the innovative approach of companies to upgrade their products and services. The interest in these new industries, in fact, traditional industries driven by disruptive ideas, is increasing within the business world in accordance with their high-growth potential, social performances, and innovation. Among the most important emerging business sectors, the biopharmaceutical industry attempts to create a very attractive commitment for increasing people’s lives, through biological substances and biotechnological means, leaving behind the traditional drugs manufactured through chemical substances. Structured in two parts, this study firstly summarizes the stages of industries’ life cycles and the characteristics, challenges, and importance of emerging industries. Secondly, it presents the case of biopharma industry emergence, with a focus on the determinant factors of industry emergence and the sources of competitive advantage of biopharma industry.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 340 Zeitschriften

aus folgenden Fachgebieten:

Bauwesen + Immobilien
Business IT + Informatik
Finance + Banking
Management + Führung
Marketing + Vertrieb
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Nächstes Kapitel The Hiramatsu Concept of “One Village, One Product” as an Element of Regional Industrial Specialization and a Cluster Policy Tool

Allied Market Research. (2018). Biopharmaceuticals market—global opportunity analysis and industry forecast, 2018-2025. Retrieved from https://www.alliedmarketresearch.com/biopharmaceutical-market

Audretsch, D. B. (2020). Entrepreneurship and culture. Eurasian Economic Review, 10, 1–8.CrossRef

Birch, K. (2017). Innovation, regional development and the life sciences (1st ed.). New York: Taylor & Francis.

Bjørgum, Ø. (2016). MNCs entering an emerging industry: The choice of governance mode under high uncertainty. Cogent Business & Management, 3(1). https://doi.org/10.1080/23311975.2016.1258135.

Clarivate Analytics. (2018). The life sciences innovation report. Retrieved from https://www.clarivate.com/wp-content/uploads/dlm_uploads/2018/10/Life-Sciences-Innovation-2018.pdf

Czarnitzki, D., Rammer, C., & Toole, A. A. (2014). University spin-offs and the “performance premium”. Small Business Economics. Retrieved from https://doi.org/10.1007/s11187-013-9538-0

Decarolis, D. M., & Deeds, D. L. (1999). The impact of stocks and flows of organizational knowledge on firm performance: An empirical investigation of the biotechnology industry. Strategic Management Journal, 20, 953–968.

Deloitte. (2019). 2019 Global life sciences outlook. Retrieved from https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-lshc-ls-outlook-2019.pdf

Ernst and Young. (2019). EY Tax Insights. Retrieved from https://taxinsights.ey.com/archive/archive-articles/pharmaceutical-randd-tax-incentives.aspx

European Cluster Observatory. (2012). Cluster-specific framework conditions for world-class clusters in emerging industries. Brussels. Retrieved from https://ec.europa.eu/docsroom/documents/16266/attachments/1/translations/en/renditions/native

European Cluster Observatory. (2014). European cluster panorama 2014. Brussels: European Commission. Retrieved from http://ec.europa.eu/DocsRoom/documents/7242/attachments/1/translations/en/renditions/pdf

European Cluster Observatory. (2016). European cluster panorama 2016. Brussels: European Cluster Observatory. Retrieved from http://ec.europa.eu/DocsRoom/documents/20381

European Commission. (2013). Horizon 2020—Work Programme 2014–2015. European Commission Decision C (2015)2453 of 17 April 2015). Brussels: Publications Office of the European Union.

European Investment Fund. (2017). Financing micro firms in Europe: An empirical analysis (no. 2017/44) (EIF Working Paper). Retrieved from https://www.eif.org/news_centre/publications/eif_wp_44.pdf

European Savings and Retail Banking Group. (2016). Financial systems in Europe and the United States: Structural differences where banks remain the main source of finance for companies. Bruxelles. Retrieved from https://www.wsbi-esbg.org/SiteCollectionDocuments/EU-US.study.ESBG%20May.2016.pdf

Fontes, M. (2005). The process of transformation of scientific and technological knowledge into economic value conducted by biotechnology spin-offs. Technovation, 25, 339–347. https://doi.org/10.1016/j.technovation.2003.08.004

Food and Drug Administration. (2019). Medical device safety action plan: Protecting patients, promoting public health. Retrieved from https://www.fda.gov/about-fda/cdrh-reports/medical-device-safety-action-plan-protecting-patients-promoting-public-health

Forbes, D. P., & Kirsch, D. A. (2011). The study of emerging industries: Recognizing and responding to some central problems. Journal of Business Venturing, 26, 589–602. https://doi.org/10.1016/j.jbusvent.2010.01.004

Gustafsson, R., Jääskeläinen, M., Maula, M., & Uotila, J. (2016). Emergence of industries: A review and future directions. International Journal of Management Reviews, 18, 28–50. https://doi.org/10.1111/ijmr.12057

Horii, R. (2011). Wants and past knowledge: Growth cycles with emerging industries. Journal of Economic Dynamics & Control, 36, 220–238. https://doi.org/10.1016/j.jedc.2011.08.001

Jagschies, G., Sofer, G. K., & Hagel, l. (2007). Biopharmaceuticals today. In G. Jagschies, G. K. Sofer, & I. Hagel (Eds.), Handbook of process chromatography: Development, manufacturing, validation and economics (pp. 1–22). Amsterdam: Elsevier.

Jong, S. (2006). How organizational structures in science shape spin-off firms: The biochemistry departments of Berkeley, Stanford, and UCSF and the birth of the biotech industry. Industrial and Corporate Change, 15(2), 251–283. https://doi.org/10.1093/icc/dtj014.CrossRef

Ketels, C. H., & Memedovic, O. (2008). From clusters to cluster-based economic development. International Journal of Technological Learning, Innovation and Development, 1(3), 375–392.CrossRef

Kleyn, D., Kitney, R., & Atun, R. A. (2007). Partnership and innovation in the life sciences. International Journal of Innovation Management, 11(2), 323–347.CrossRef

KPMG. (2018). Site selection for life sciences companies in Europe. Retrieved from https://home.kpmg/be/en/home/insights/2019/05/site-selection-for-life-sciences-companies.html

Low, M. B., & Abrahamson, E. (1997). Movements, bandwagons and clones, industry evolution and the entrepreneurial process. Journal of Business Venturing, 12, 435–457.

Phall, R., O’Sullivan, E., Routley, M., Ford, S., & Probert, D. (2011). A framework for mapping industrial emergence. Technological Forecasting & Social Change, 78, 217–230. https://doi.org/10.1016/j.techfore.2010.06.018

Porter, M. E. (1980). Competitive strategy: Techniques for analyzing industries and competitors. New York: Free Press.

Porter, M. E. (1990). The competitive advantage of nations. New York: Free Press.CrossRef

Porter, M. E. (1998). Clusters and competition, new agendas for companies, governments and institutions. In M. E. Porter (Ed.), On competition. Boston, MA: Harvard Business School Press.

QS World University Rankings. (2019). The top 500 universities in the world 2019. Retrieved from http://info.qs.com/rs/335-VIN-535/images/qswur_2019_top_500_supplement.pdf

Rader, R. A. (2008). (Re)defining biopharmaceutical. Nature Biotechnology, 26(7), 743–751.CrossRef

Rong, K., Shi, Y., & Yu, J. (2013). Nurturing business ecosystems to deal with industry uncertainties. Industrial Management & Data Systems, 113(3), 385–402. https://doi.org/10.1108/02635571311312677

Russo, M. (2003). The emergence of sustainable industries: Building on natural capital. Strategic Management Journal, 24, 317–331. https://doi.org/10.1002/smj.298

Seretakis, A. (2012). A comparative examination of private equity in the United States and Europe: Accounting for the past and predicting the future of European private equity. The Fordham Journal of Corporate & Financial Law, 18, 613.

United Nations. (2017). World population prospects: The 2017 revision. New York: Department of Economic and Social Affairs, Population Division. Retrieved from https://population.un.org/wpp/Publications/Files/WPP2017_KeyFindings.pdf

Titel: The Importance of Emerging Industries: The Case of Biopharma
verfasst von: Cristina Porumboiu
Verlag: Springer International Publishing
Buch: Eurasian Economic Perspectives
Print ISBN: 978-3-030-48530-6

Electronic ISBN: 978-3-030-48531-3

Copyright-Jahr: 2020
DOI: https://doi.org/10.1007/978-3-030-48531-3_1

Springer Professional

Abstract

Bitte loggen Sie sich ein, um Zugang zu Ihrer Lizenz zu erhalten.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Technik"

Springer Professional "Wirtschaft"